MYD88 and neoplasm: Specifically, LATS1/2-null or YAP/TAZ-activated tumor cells could secrete nucleic acid-rich extracellular vesicles that stimulated the host TLR-MYD88/TRIF-IFN pathway to induce antitumor immunity and the eventual elimination of tumor cells [140].